The recent application of recombinant DNA technology to clinical inves
tigation now allows the identification of the molecular alterations re
sponsible for insulin resistance. In this review, the recent knowledge
concerning these investigations is reported. Genetic mutations of the
insulin gene as the source of insulin resistance have been reported f
or a long time. More recently a series of mutations of the insulin rec
eptor gene have been identified as the cause of the extreme insulin re
sistance, observed in rare syndromes, such as type A insulin resistanc
e or leprechaunism. However, it is probable that the majority of the m
olecular defects causing insulin resistance occur at the postreceptor
level. The key proteins involved in the different intracellular signal
ling pathways of insulin are only partly identified. A better understa
nding of the mechanisms of insulin action is essential for the identif
ication of corresponding genetic alterations. The investigations conce
rning the glucose transporter GLUT4 and glucokinase genes are good exa
mples of complex but promising research, which has recently started. E
lucidation of the genetic and molecular basis of diseases such as type
Il diabetes or other states associated with insulin resistance, is th
e long-term goal.